Skip to content
Open access

OTULIN aggravate aneurysm/aortic dissection by promoting vascular smooth muscle cell phenotype switching via the DDX17 -FGF2 Axis

Oct 2026 · European Heart Journal · Vol 47 · 0 citations

TL;DR

It is demonstrated that OTULIN acts as a pathological driver of AAD by destabilizing DDX17 and activating the FGF2 axis and targeting OTULIN may represent a novel therapeutic strategy for AAD.

Abstract

Aortic aneurysm/dissection (AAD) is a life-threatening disease lacking effective pharmacological treatment. Protein ubiquitination plays a pivotal role in cardiovascular diseases. However, the possible contribution of the deubiquitinating enzyme OTULIN (OTU deubiquitinase with linear linkage specificity) to AAD pathogenesis remains elusive. Through integrative analysis of RNA-sequencing data from human and mouse AAD tissues with a deubiquitinase database, we identified OTULIN as a key candidate. We generated vascular smooth muscle cell (VSMC)-specific OTULIN knockout mice and established an AAD model using β-aminopropionitrile (BAPN). We employed multiple molecular biological techniques to explore the role of OTULIN in VSMC phenotype switching. We found that OTULIN was significantly increased in AAD patients and BAPN-induced AAD mice. VSMC-specific OTULIN knockout ameliorated BAPN-induced AAD, whereas VSMC-specific overexpression by rAAV9-SM22α-OTULIN (recombinant adeno-associated virus serotype 9 expressing Flag-tagged OTULIN under SM22α promoter) aggravated BAPN-induced AAD progression. Mechanistically, we identified DDX17 (DEAD-box helicase 17) as a substrate of OTULIN through interactome analysis. OTULIN removed the linear ubiquitin of DDX17 and promoted its proteasomal degradation. Consequently, Angiotensin II-induced DDX17 downregulation activated FGF2 transcription, leading to VSMC phenotype switching. Our findings demonstrate that OTULIN acts as a pathological driver of AAD by destabilizing DDX17 and activating the FGF2 axis. Targeting OTULIN may represent a novel therapeutic strategy for AAD.

Read PDF

Similar papers

Open access Oct 2026

Pyruvate dehydrogenase kinase 4 Triggers VSMCs phenotype switching and aortic aneurysm/dissection by regulating NLRP3 lactylation

Aortic aneurysm/dissection (AAD) represents a life-threatening cardiovascular disorder characterized by vascular smooth muscle cells (VSMCs) phenotype switching from contractile to synthetic type and inflammatory responses. Current clinical management of AAD primarily relies on surgical intervention with little e...

D. Yang, J. Liu, Da-Dao-Yi Zhao et al. · 0 citations
Open access Oct 2026

SPOCK2-mediated phenotype switch of vascular smooth muscle cells contributes to aortic aneurysm in Kawasaki disease

Background Coronary artery aneurysm is a major cardiovascular complication of Kawasaki disease (KD). The phenotype switch of vascular smooth muscle cells (VSMCs) plays a crucial role in pathological vascular wall remodeling in KD; however, the molecular mechanisms driving this process remain incompletely understood. Al...

Xiao Xu, Yu-Cong Wei, Min Wang et al. · 0 citations
Open access Nov 2026

MEX3B leads to aberrant expression of VCAN, aggravating the thoracic aortic dissection by contributing to the phenotype transformation of VSMCs.

Thoracic aortic dissection (TAD) is a lethal condition due to the risk of aortic rupture and malperfusion of arterial branches. Currently, effective treatments are unavailable due to the unclear pathogenic mechanisms; therefore, it is essential to explore the underlying mechanisms of TAD to find novel therapeutic targe...

Jian-Mao Hong, Bi-Jun Xu, Shi-Qiang Wang et al. · 0 citations
Nov 2026

Abstract 14425: Cyclin Y Protects Against Thoracic Aortic Dissection by Preserving Mitochondrial Fatty Acid Homeostasis in Vascular Smooth Muscle Cells

Background: Thoracic aortic dissection (TAD) is a life-threatening vascular disease marked by medial degeneration, vascular smooth muscle cell (VSMC) loss, and extracellular matrix disruption, yet its underlying mechanisms remain poorly understood. Cyclin Y (CCNY), a cyclin family member involved in cellular homeost...

Kevin Chai · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.